Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 113 participants.
Also called NCT01265524
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 113 participants
- Sponsor
- Sorbent Therapeutics
- Registry
-
NCT01265524
-
- Main results
- A double-blind, randomized, parallel, placebo-controlled study examining the effect of cross-linked polyelectrolyte in heart failure patients with chronic kidney disease
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- Not reported
- Results first posted
- Countries
- Armenia, Georgia, Moldova
- Registry status
- Completed
Technical summary
Registry record NCT01265524. Randomized; quadruple masking; primary purpose prevention. Start 2011-04 (registry gives no type); primary completion 2011-11 (actual). Results posted on 2013-03-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease
- Condition
- Heart Failure
- Intervention (Drug)
- CLP
- Intervention (Drug)
- Placebo
- Lead sponsor
- Sorbent Therapeutics
- Collaborator
- Pharmaterra
Record details
- Record id
cardio:ct-nct01265524- Content hash
c8a8bd16b3b7a2bb9247423b13478c716aef336ab41097ea03ba981a43d8563b